215 research outputs found
Salmeterol and Airway Response to Allergen
No full textBACKGROUND: Regular treatment with inhaled salbutamol (seven to 14 days) increases airway responsiveness to allergen
Serine proteases decrease intestinal epithelial ion permeability by activation of protein kinase Cζ
No full text
A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses.
No full textAdditional file 5: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma
No full textCONSORT 2010 checklist. (DOC 218 kb
Additional file 2: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma
No full textSchedule of assessments during the clinical trial study. (DOCX 102 kb
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses
No full textAdditional file 4: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma
No full textIncidence of adverse events (AEs). (DOCX 15 kb
- …
